Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point-Reference-Cited by-同舟云学术

Prescription Drug Spending Trends In The United States: Looking Beyond The Turning Point

Published:2008-01 Issue:Suppl1 Volume:27 Page:w151-w160
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Aitken Murray¹,Berndt Ernst R.¹,Cutler David M.¹

Affiliation:

1. Murray Aitken is senior vice president, Healthcare Insight, at IMS Health in Norwalk, Connecticut. Ernst Berndt () is the Louis E. Seley Professor in Applied Economics, Alfred P. Sloan School of Management, at the Massachusetts Institute of Technology in Cambridge. David Cutler is a professor of economics at Harvard University in Cambridge.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference12 articles.

1. The Long Shadow of Patent Expiration

2. The Long Shadow of Patent Expiration

3. The Long Shadow of Patent Expiration

4. Authorized Generic Drugs, Price Competition, And Consumers’ Welfare

5. Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generic competition and the incentives for early-stage pharmaceutical innovation;Research Policy;2022-12

2. Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs;Health Economics;2022-11-18

3. Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018;JAMA Network Open;2021-11-22

4. Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 to 2016;Circulation;2021-07-27

5. Determinants of Growth in Prescription Drug Spending Using 2010–2019 Health Insurance Claims Data;Frontiers in Pharmacology;2021-05-31